| |
| | Biogen and Ontogeny Extend Hedgehog Protein Research Collaboration |
 | | CAMBRIDGE, Mass., Feb. 23 /PRNewswire/ -- Biogen, Inc. (Nasdaq: BGEN) and Ontogeny, Inc., a privately held biotechnology company and leader in the field of developmental biology, today announced the extension and expansion of their existing agreement to collaborate on the discovery and commercialization of three cell differentiation factors from the Hedgehog gene family. |
 | | Ontogeny has strong core technologies, proprietary positions and solid data validating the role of the hedgehog protein family. |
 | | Ontogeny, Inc., located in Cambridge, MA, and founded in 1994, is a privately held company whose mission is to be the preeminent biopharmaceutical company utilizing developmental biology to create therapeutics that will significantly improve the quality of life by activating the body's ability to repair and regenerate. |
| www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/02-23-1999/0000876297&EDATE= (586 words) |
|